Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 270 | -350 | 10 | 460 | N/A |
| Depreciation Amortization | 370 | 500 | 0 | 0 | N/A |
| Other Working Capital | -80 | -380 | 0 | 0 | N/A |
| Other Operating Activity | -210 | -110 | -620 | -210 | 0 |
| Operating Cash Flow | $350 | $-340 | $-610 | $250 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -820 | -230 | -260 | -510 | N/A |
| Net Acquisitions | 10 | 0 | 0 | 0 | N/A |
| Other Investing Activity | 90 | 222 | 460 | -250 | 0 |
| Investing Cash Flow | $-720 | $-8 | $200 | $-760 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 100 | -130 | 690 | 500 | 0 |
| Financing Cash Flow | $100 | $-130 | $690 | $500 | $N/A |
| Exchange Rate Effect | 10 | -10 | 50 | -10 | N/A |
| Beginning Cash Position | 950 | 1,450 | 1,150 | 1,170 | N/A |
| End Cash Position | 690 | 950 | 1,490 | 1,150 | N/A |
| Net Cash Flow | $-250 | $-490 | $330 | $-20 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 350 | -340 | -610 | 250 | N/A |
| Free Cash Flow | 350 | -340 | -610 | 250 | 0 |